Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · October 03, 2022

MRD Dynamics During Ixazomib Maintenance for Improved Prognostication of Patients With Myeloma



Additional Info

Disclosure statements are available on the authors' profiles:

MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials
Blood 2022 Sep 21;[EPub Ahead of Print], B Paiva, I Manrique, MA Dimopoulos, F Gay, CK Min, S Zweegman, I Spicka, R Teipel, MV Mateos, N Giuliani, M Cavo, C Rojas, W Fu, K Suryanarayan, A Vorog, C Li, B Wang, J Estevam, R Labotka, AB Dash

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading